Sorbitol, osmoregulation, and the complications of diabetes.
作者信息
Burg M B, Kador P F
机构信息
National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.
出版信息
J Clin Invest. 1988 Mar;81(3):635-40. doi: 10.1172/JCI113366.
Abstract
摘要
相似文献
1
Sorbitol, osmoregulation, and the complications of diabetes.
J Clin Invest. 1988 Mar;81(3):635-40. doi: 10.1172/JCI113366.
2
Role of aldose reductase and sorbitol in maintaining the medullary intracellular milieu.
Kidney Int. 1988 Mar;33(3):635-41. doi: 10.1038/ki.1988.46.
3
[Pathobiochemistry of the late-onset diabetic syndrome].
Med Klin. 1974 Sep 6;69(36):1417-23.
4
Etiology of cataracts in diabetics.
Int Ophthalmol Clin. 1984 Winter;24(4):93-110.
5
The diabetic cornea.
Int Ophthalmol Clin. 1984 Winter;24(4):111-23.
6
Organic osmolytes in diabetes mellitus.
Exp Nephrol. 1994 Jan-Feb;2(1):18-23.
7
[Sorbitol and its role in nutrition].
Vopr Pitan. 1983(1):3-5.
8
Molecular basis for osmoregulation of organic osmolytes in renal medullary cells.
J Exp Zool. 1994 Feb 1;268(2):171-5. doi: 10.1002/jez.1402680216.
9
Cellular osmoregulation in kidney medulla.
Contrib Nephrol. 1998;123:169-84. doi: 10.1159/000059912.
引用本文的文献
1
Targeting pericyte retention in Diabetic Retinopathy: a review.
Ann Med. 2024 Dec;56(1):2398200. doi: 10.1080/07853890.2024.2398200. Epub 2024 Sep 13.
2
Gene expression in the dorsal root ganglion and the cerebrospinal fluid metabolome in polyneuropathy and opioid tolerance in rats.
IBRO Neurosci Rep. 2024 May 24;17:38-51. doi: 10.1016/j.ibneur.2024.05.006. eCollection 2024 Dec.
3
HIF-1 inhibition reverses opacity in a rat model of galactose-induced cataract.
PLoS One. 2024 Feb 28;19(2):e0299145. doi: 10.1371/journal.pone.0299145. eCollection 2024.
4
Glutamate is effective in decreasing opacity formed in galactose-induced cataract model.
Sci Rep. 2024 Feb 19;14(1):4123. doi: 10.1038/s41598-024-54559-y.
5
In-silico molecular designs to treat neurologic and ophthalmologic diseases caused by sorbitol excess: engineering the Agrobacterium vitis protein.
BMC Res Notes. 2023 Jul 3;16(1):129. doi: 10.1186/s13104-023-06367-2.
6
Erythritol synthesis is elevated in response to oxidative stress and regulated by the non-oxidative pentose phosphate pathway in A549 cells.
Front Nutr. 2022 Oct 6;9:953056. doi: 10.3389/fnut.2022.953056. eCollection 2022.
7
Pathophysiology and Molecular Imaging of Diabetic Foot Infections.
Int J Mol Sci. 2021 Oct 26;22(21):11552. doi: 10.3390/ijms222111552.
8
Dietary Diversification and Specialization in Neotropical Bats Facilitated by Early Molecular Evolution.
Mol Biol Evol. 2021 Aug 23;38(9):3864-3883. doi: 10.1093/molbev/msab028.
9
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.
Cardiovasc Endocrinol Metab. 2020 May 18;10(1):3-13. doi: 10.1097/XCE.0000000000000209. eCollection 2021 Mar.
10
Metabolomic Analysis of Infection in S2 Cells Reveals Divergent Effects on Central Carbon Metabolism as Compared with Silkworm Bm5 Cells.
Viruses. 2020 Apr 1;12(4):393. doi: 10.3390/v12040393.
本文引用的文献
1
Living with water stress: evolution of osmolyte systems.
Science. 1982 Sep 24;217(4566):1214-22. doi: 10.1126/science.7112124.
2
Corneal re-epithelialization in galactosemic rats.
Invest Ophthalmol Vis Sci. 1983 May;24(5):563-9.
3
The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
Diabetes. 1982 Sep;31(9):789-94. doi: 10.2337/diab.31.9.789.
4
Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991-1001. doi: 10.1136/jnnp.44.11.991.
5
Corneal endothelial changes in type I and type II diabetes mellitus.
Am J Ophthalmol. 1984 Oct 15;98(4):401-10. doi: 10.1016/0002-9394(84)90120-x.
6
Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.
N Engl J Med. 1983 Jan 20;308(3):119-25. doi: 10.1056/NEJM198301203080302.
7
Experimental galactosemia produces diabetic-like retinopathy.
Diabetes. 1984 Jan;33(1):97-100. doi: 10.2337/diab.33.1.97.
8
A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.
Diabetes. 1983 Oct;32(10):938-42. doi: 10.2337/diab.32.10.938.
9
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.
Neurosci Lett. 1982 Aug 16;31(2):189-93. doi: 10.1016/0304-3940(82)90115-x.
10
Mechanisms initiating cataract formation. Proctor Lecture.
Invest Ophthalmol. 1974 Oct;13(10):713-24.
Zotero 插件